Histopathologically detected extranodal extension leads to upstaging and treatment escalation in head and neck squamous cell carcinoma. There is considerable variation in the prevalence of histopathologically detected extranodal extension in comparable studies. The Head and Neck Cancer International Group, which includes 23 organisations managing patients with head and neck cancer, identified several challenges in evaluating histopathologically detected extranodal extension. Thus,…
[Policy Review] International consensus recommendations and alignment of terminology for the histopathological diagnosis of extranodal extension in head and neck squamous cell carcinoma: an HN-CLEAR initiative
The Lancet Oncology | | Ruta Gupta, Timothy Fielder, Munita Bal, Simion I Chiosea, Jane E Dahlstrom, Aanchal Kakkar, Katalin Kiss, Jan Laco, Neha Mittal, Sunil Pasricha, Spinder Samra, Nina Zidar, Martin Bullock, Rebecca Chernock, William Faquin, Mary S Richardson, D Neil Hayes, Shao Hui Huang, Jean Yang, Ziyad Alsugair, Nazim Benzerdjeb, Shaun Chou, Caroline Cooper, Katarina Dimnik, Rimlee Dutta, Ricardo Santiago Gomez, Juan C Hernandez-Prera, Meenakshi Kamboj, Tina Klitmøller Agander, Ankur Kumar, Jenny T H Lee, Diana M Bell, Toshitaka Nagao, Masato Nakaguro, Timothy Onyuma, Ji Hyun Park, Jin Woo Park, Asawari Patil, Miroslav Podhola, Swapnil Rane, Sean A Rasmussen, Tomáš Rozkoš, Prarthna Shah, Divakar Sharma, Stefi Stefi, Antje Stubsgaard, Ana Cristina Tetzner, Bruce M Wenig, William H Westra, Laura Wise, Sun Och Yoon, HN-CLEAR steering committee and clinical advisory group
Topics: blood-cancer, cervical-cancer, head-neck-cancer